JPH0789863B2 - Cream for beverages containing peroxidase - Google Patents
Cream for beverages containing peroxidaseInfo
- Publication number
- JPH0789863B2 JPH0789863B2 JP13541786A JP13541786A JPH0789863B2 JP H0789863 B2 JPH0789863 B2 JP H0789863B2 JP 13541786 A JP13541786 A JP 13541786A JP 13541786 A JP13541786 A JP 13541786A JP H0789863 B2 JPH0789863 B2 JP H0789863B2
- Authority
- JP
- Japan
- Prior art keywords
- cream
- coffee
- peroxidase
- hydrogen peroxide
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000006071 cream Substances 0.000 title claims description 57
- 102000003992 Peroxidases Human genes 0.000 title claims description 54
- 108040007629 peroxidase activity proteins Proteins 0.000 title claims description 50
- 235000013361 beverage Nutrition 0.000 title claims description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 68
- 235000016213 coffee Nutrition 0.000 description 49
- 235000013353 coffee beverage Nutrition 0.000 description 49
- 210000004027 cell Anatomy 0.000 description 31
- 231100000299 mutagenicity Toxicity 0.000 description 24
- 230000007886 mutagenicity Effects 0.000 description 24
- 244000269722 Thea sinensis Species 0.000 description 21
- 231100000135 cytotoxicity Toxicity 0.000 description 19
- 230000003013 cytotoxicity Effects 0.000 description 19
- 230000000694 effects Effects 0.000 description 16
- 238000000034 method Methods 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 235000013616 tea Nutrition 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 235000013305 food Nutrition 0.000 description 9
- 235000006468 Thea sinensis Nutrition 0.000 description 8
- 235000020279 black tea Nutrition 0.000 description 8
- 235000021539 instant coffee Nutrition 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000607142 Salmonella Species 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 240000003291 Armoracia rusticana Species 0.000 description 5
- 235000011330 Armoracia rusticana Nutrition 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000007758 minimum essential medium Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 102000016607 Diphtheria Toxin Human genes 0.000 description 4
- 108010053187 Diphtheria Toxin Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 108700020962 Peroxidase Proteins 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000003505 mutagenic effect Effects 0.000 description 4
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 230000005757 colony formation Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 231100000219 mutagenic Toxicity 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- 231100000707 mutagenic chemical Toxicity 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 206010007269 Carcinogenicity Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000533293 Sesbania emerus Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 231100000260 carcinogenicity Toxicity 0.000 description 2
- 230000007670 carcinogenicity Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- WDGFFVCWBZVLCE-UHFFFAOYSA-N purpurogallin Chemical group C1=CC=C(O)C(=O)C2=C1C=C(O)C(O)=C2O WDGFFVCWBZVLCE-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- GPHSJPVUEZFIDE-UHFFFAOYSA-N 7-hydroxy-2,5,7-trimethyl-3a-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[3,7a-dihydro-2h-indene-6,1'-cyclopropane]-1-one Chemical compound C1=C(C)C2(CC2)C(C)(O)C2C(=O)C(C)CC21OC1OC(CO)C(O)C(O)C1O GPHSJPVUEZFIDE-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 241000533845 Enterolobium cyclocarpum Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000045576 Lactoperoxidases Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GMGWMIJIGUYNAY-UHFFFAOYSA-N MeIQ Chemical compound CC1=CC2=NC=CC=C2C2=C1N(C)C(N)=N2 GMGWMIJIGUYNAY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 235000021336 beef liver Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 231100000010 clastogenicity Toxicity 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000032537 response to toxin Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Landscapes
- Dairy Products (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、ペルオキシダーゼを配合したコーヒー、紅茶
等の飲料用クリームに関する。本発明のクリームは、飲
用時にコーヒー、紅茶中に発生する過酸化水素を分解す
ることによつて、当該飲料の細胞毒性を低下せしめ、ま
た同時に当該飲料の突然変異原性を不活性化せしめるこ
とを目的とする。TECHNICAL FIELD The present invention relates to a cream for beverages such as coffee and tea containing peroxidase. The cream of the present invention reduces the cytotoxicity of the beverage by decomposing hydrogen peroxide generated in coffee and tea during drinking, and at the same time inactivates the mutagenicity of the beverage. With the goal.
(従来技術) 食品中の変異原をペルオキシダーゼにより消去すること
は、本発明者らの発明に係る特開昭60−6294号公報に開
示されているが、本発明はその改良に関するものであ
る。(Prior Art) Elimination of mutagens in foods by peroxidase is disclosed in Japanese Patent Application Laid-Open No. 60-6294 related to the inventors of the present invention, and the present invention relates to improvement thereof.
(発明が解決しようとする技術課題) 飲食品の安全性がヒトの健康にとつて重大な問題である
ことは言うまでもない。ここで、飲食品の安全性とは具
体的には飲食品がヒトの健康に悪影響を及ぼすもの(病
原菌,毒物)を含有していないことを基本的に意味して
いる。食品産業により生産された製品の微生物管理につ
いては、各社とも厳重な滅菌、除菌工程を施しており、
また脱酸素剤のように微生物の生育を困難にさせる基剤
も開発されているため問題化することは現在では稀であ
る。しかしながら、毒物については、未解決の問題が多
く残つている。すなわち、フリルフラマイド(AF−
2)、サイクラミン酸塩(チクロ)、過酸化水素のよう
に発癌性が明らかにされた食品添加物については使用が
禁止されたり、残留してはならないとされ、食品添加物
から排除されてきたが、アクイライド(Aquilide)Aの
ように食用にする植物に本来含まれる発癌物質や、Trp
−P−1,MeIQのように食肉の調理過程で内因的に生成す
る発癌物質については、それらの危険性を単なる法的規
制によつて排除することはできない。(Technical problem to be solved by the invention) It goes without saying that safety of food and drink is a serious problem for human health. Here, the safety of foods and drinks basically means that the foods and drinks do not contain substances (pathogens, poisons) that adversely affect human health. Regarding microbial control of products produced by the food industry, each company has undergone strict sterilization and sterilization processes,
In addition, a base such as an oxygen scavenger that makes growth of microorganisms difficult has been developed, so that it is rarely a problem at present. However, there are many unsolved problems regarding poisons. That is, frill flamide (AF-
2), the use of food additives such as cyclamate (cyclo) and hydrogen peroxide whose carcinogenicity has been revealed is prohibited or should not remain, and has been excluded from food additives. Is a carcinogen originally contained in edible plants such as Aquilide A, and Trp
-For carcinogens such as P-1, MeIQ, which are generated endogenously during the cooking process of meat, their risks cannot be excluded by mere legal regulation.
このため、これらの毒物に対する分解・除去方法の開発
は、現にこれらの物質を含む飲食品を摂取するヒトの健
康にとつて最も重要な課題となつてきている。Therefore, the development of a method for decomposing / removing these poisons has become the most important issue for the health of humans who actually ingest foods and drinks containing these substances.
本発明者らは、コーヒーのヒト小腸細胞に対する細胞毒
性や突然変異原性について検討した結果、コーヒーをつ
くつた直後に(すなわち、インスタントコーヒーの場
合、コーヒー粉末を水あるいはお湯で溶かした直後、レ
ギュラーコーヒーの場合、焙煎したコーヒー豆を抽出し
た直後)、過酸化水素がコーヒー成分の自動酸化により
発生することを認めた(第1図)。The present inventors have examined the cytotoxicity and mutagenicity of coffee on human small intestinal cells, and as a result, immediately after making coffee (that is, in the case of instant coffee, immediately after dissolving coffee powder in water or hot water, regular coffee). In the case of coffee, immediately after extraction of roasted coffee beans), it was confirmed that hydrogen peroxide was generated by autoxidation of coffee components (Fig. 1).
第1図によれば、過酸化水素は、コーヒー粉末を水に溶
かした直後から発生し、その濃度は時間の経過とともに
上昇した。これに対して、嫌気条件下(100%N2)でつ
くつたコーヒー溶液では過酸化水素は検出されなかつ
た。好気条件下でつくつたコーヒーを嫌気条件下に移す
と過酸化水素濃度の上昇は止まるが、濃度低下は見られ
なかつた。According to FIG. 1, hydrogen peroxide was generated immediately after the coffee powder was dissolved in water, and the concentration thereof increased with time. In contrast, hydrogen peroxide was not detected in the coffee solution prepared under anaerobic conditions (100% N 2 ). When the coffee produced under aerobic conditions was transferred to anaerobic conditions, the hydrogen peroxide concentration stopped increasing, but the concentration did not decrease.
同様な報告は、ナガオ(Nagao),M.ら、Banbury Report
17:Coffee and Health,pp69−77,Cold Spring Harbor
Laboratory,1984にもなされている。Similar reports can be found in Nagao, M. et al., Banbury Report.
17: Coffee and Health, pp69-77, Cold Spring Harbor
Also done in Laboratory, 1984.
過酸化水素の濃度はインスタントコーヒー(15mg粉末/m
l,溶解5分後)で2.4±1.2ppm、レギュラーコーヒーで1
0.6±4.8ppmであつた。しかして、後述の実施例に示す
とおり、過酸化水素を酵素的に分解すると、コーヒーの
上記細胞毒性は著しく低下し、突然変異原性もほとんど
消失することが本発明者らにより見出された。過酸化水
素が両毒性の主因と考えられる。The concentration of hydrogen peroxide is instant coffee (15 mg powder / m
l, 5 minutes after dissolution) 2.4 ± 1.2 ppm, 1 with regular coffee
It was 0.6 ± 4.8 ppm. Therefore, as shown in the Examples below, the present inventors have found that enzymatic decomposition of hydrogen peroxide significantly reduces the above-mentioned cytotoxicity of coffee and almost eliminates mutagenicity. . Hydrogen peroxide is considered to be the main cause of amphoteric toxicity.
また、コーヒー以外の飲料については過酸化水素の発生
の有無及び程度を調べた結果、コーヒーよりは濃度が低
いものの、紅茶にも過酸化水素が1ppm前後発生するこ
と、及び過酸化水素を酵素的に分解することにより紅茶
のヒト小腸細胞への毒性、あるいは突然変異原性も低下
することが明らかになつた。In addition, as a result of examining the presence and degree of hydrogen peroxide generation in beverages other than coffee, it was found that even though the concentration was lower than that of coffee, hydrogen peroxide was generated at around 1 ppm in black tea, and hydrogen peroxide was enzymatically generated. It was clarified that the degradation of tea into human small intestinal cells and its mutagenicity were also reduced by the decomposition into black tea.
過酸化水素の毒性は既に明らかにされているとおりであ
り〔イトウ(Ito),A.ら,Gann,Vol.73,315−322,1982;
タツカー(Thacker),J.,Mutation Res.,Vol.33,147−1
56,1975〕、加熱工程(焙煎,調理を含む)や乾燥工程
を含む飲食品から過酸化水素が発生すれば、突然変異原
性や細胞毒性に関して好ましくない影響を有すると考え
られる。The toxicity of hydrogen peroxide has already been clarified [Ito, A. et al., Gann, Vol. 73, 315-322, 1982;
Thacker, J., Mutation Res., Vol.33,147-1
56,1975], the production of hydrogen peroxide from foods and drinks including the heating step (including roasting and cooking) and the drying step is considered to have an unfavorable effect on mutagenicity and cytotoxicity.
従つて、これを酵素的に分解することは、日常的にこれ
らの飲食品を摂取するヒトの健康を守る上で十分に有意
義であると考えられる。因みに、厚生省は食品における
過酸化水素の残留をゼロにするように告示している(19
80)。また、現在市販されているコーヒー、紅茶用クリ
ームのうち、粉状、あるいは液状のもの併せて10種につ
いて調べたところでは、いずれも過酸化水素を分解せ
ず、コーヒー、紅茶の細胞毒性や突然変異原性も各クリ
ーム添加により全く変化しなかつた(第2図及び第3
図)。Therefore, enzymatically decomposing this is considered to be sufficiently significant to protect the health of humans who ingest these foods and drinks on a daily basis. Incidentally, the Ministry of Health and Welfare has announced that there should be zero residual hydrogen peroxide in food (19).
80). In addition, among the coffee and tea creams currently on the market, 10 kinds of powdery or liquid creams were examined, and none of them decomposed hydrogen peroxide, and the cytotoxicity and sudden Mutagenicity did not change at all by addition of each cream (Figs. 2 and 3).
Figure).
第2図は、市販クリーム(3種;他に7種について検討
した)は、コーヒーの突然変異原性に対していずれも何
ら影響を与えなかつたことを示す。Figure 2 shows that none of the commercial creams (3; 7 others examined) had any effect on coffee mutagenicity.
第3図は、市販クリーム(クリーミングパウダー)はコ
ーヒーのヒト小腸細胞に対する細胞毒性に関して何ら効
果を示さなかつたことを示す。なお、クリームは4種類
(4ブランド)検討したが、全て第3図の白丸と同一の
結果を示したので、3種類(3ブランド)については省
略した。また、作図上、白丸と黒丸をずらして書いてあ
るが、本来同一点を示す。FIG. 3 shows that the commercial cream (creaming powder) had no effect on the cytotoxicity of coffee on human small intestinal cells. Although four types (4 brands) of cream were examined, all of them showed the same results as the white circles in FIG. 3, so the three types (3 brands) were omitted. Also, in the drawing, the white circles and the black circles are shifted, but the points are essentially the same.
本発明は、飲用時、コーヒー、紅茶等の中に過酸化水素
が発生し、両飲料の細胞毒性、突然変異原性の原因を構
成しているという新しい知見を基に、コーヒー、紅茶用
クリームに過酸化水素を分解する酵素であるペルオキシ
ダーゼ(donor:H2O2−oxidoreductase,EC1.11.7)を配
合せしめ、当該クリームを使用することにより簡便な方
法で、コーヒー、紅茶中の過酸化水素を完全に分解さ
せ、過酸化水素の毒性(発癌性、突然変異原性、クラス
トジエネシテイー(clastogenicity)、細胞毒性)を消
失させることを意図している。The present invention is based on the new finding that hydrogen peroxide is generated in coffee, tea, etc. during drinking, which constitutes the cause of cytotoxicity and mutagenicity of both beverages. Peroxidase (donor: H 2 O 2 -oxidoreductase, EC1.11.7), which is an enzyme that decomposes hydrogen peroxide, is added to the mixture, and by using the cream, hydrogen peroxide in coffee and tea can be easily removed by a simple method. It is intended to completely decompose and eliminate the toxicity of hydrogen peroxide (carcinogenicity, mutagenicity, clastogenicity, cytotoxicity).
(発明の構成) 本発明は、ペルオキシダーゼを配合した飲料用クリーム
である。本発明に使用するペルオキシダーゼとしては、
ラクトペルオキシダーゼ、グルタチオンペルオキシダー
ゼの様な動物由来のもの、小麦胚芽や西洋ワサビのペル
オキシダーゼの様に植物に由来するもの、及び微生物に
由来するもののうち安全性の確かめられたものが使用の
対象となり得る。これらのペルオキシダーゼのうち、耐
熱性、安全性、安定性等から植物性のペルオキシダーゼ
が本発明の用途に特に適している。とりわけ、本発明で
用いる植物性ペルオキシダーゼは最終的にはヒトに摂取
されるので、昔から食用にされている植物(例えば、西
洋ワサビ、小麦胚芽、米胚芽)から安全な精製法により
分離・精製されたものを用いることが望ましい。但し、
分散性、溶解性、熱凝固性等の実用面で問題がなければ
粗精製品であつても充分である。(Structure of Invention) The present invention is a beverage cream containing peroxidase. As the peroxidase used in the present invention,
Animal-derived substances such as lactoperoxidase and glutathione peroxidase, plant-derived substances such as wheat germ and horseradish peroxidase, and microorganism-derived substances that have been confirmed to be safe can be used. Among these peroxidases, plant-based peroxidases are particularly suitable for the use of the present invention because of their heat resistance, safety and stability. In particular, since the plant peroxidase used in the present invention is finally ingested by humans, it can be isolated and purified by a safe purification method from plants that have been used for a long time (for example, horseradish, wheat germ, rice germ). It is desirable to use the one that has been used. However,
If there are no problems in practical use such as dispersibility, solubility, and heat coagulation, even a crude product is sufficient.
ペルオキシダーゼはクリームに配合する際の操作上、賦
形剤を用いて扱いを容易にしてもよい。賦形剤としては
安全で食用上、嗜好性上問題がなく吸湿性、反応性の低
いものが好ましい。例えば、ラクトースなどが適してい
る。The peroxidase may be handled easily by using an excipient in the operation when blending it into the cream. As the excipient, those which are safe, have no problems in palatability and have low hygroscopicity and reactivity are preferable. For example, lactose is suitable.
ペルオキシダーゼを配合するに当たつてのクリームの種
類は特に限定されない。クリームを粉末化したインスタ
ント粉末クリームあるいは液状クリームのいずれでもよ
いし、また牛乳由来のものでも、植物油脂で乳脂肪を置
換したものでも、配合するペルオキシダーゼ活性やその
安定性に大きな差異を生じさせない。The type of cream to be added with peroxidase is not particularly limited. It may be either an instant powder cream obtained by pulverizing the cream or a liquid cream, and whether milk-derived cream or milk fat is replaced with vegetable fat does not cause a large difference in the peroxidase activity to be incorporated or its stability.
クリームにペルオキシダーゼを配合する場合、クリー
ムが粉末の場合は、賦形剤で増量した粉状のペルオキシ
ダーゼ製剤を粉体混合するか、賦形剤とともに液状に
したペルオキシダーゼを噴霧造粒法や流動層造粒法で配
合することができ、あるいはクリームが液状の場合
は、賦形剤を用いることなく、粗精製、もしくは精製し
たペルオキシダーゼをクリームに溶解すればよい。配合
割合は使用するペルオキシダーゼの耐熱性と飲料時の飲
料の温度によつて設定が変わるが、ペルオキシダーゼ活
性が粉末クリームの場合、0.5〜60単位/gクリーム、ま
た液状クリームの場合、0.4〜50単位/ml(単位はいずれ
もプルプロガリン単位)になるように配合する。When adding peroxidase to the cream, if the cream is a powder, mix powdered peroxidase preparations that have been added with an excipient powder, or spray peroxidase liquid with the excipient by spray granulation or fluidized bed formation. It can be blended by the granule method, or when the cream is liquid, crudely purified or purified peroxidase may be dissolved in the cream without using an excipient. The blending ratio varies depending on the heat resistance of the peroxidase used and the temperature of the beverage during the beverage, but the peroxidase activity is 0.5 to 60 units / g cream for powder cream, and 0.4 to 50 units for liquid cream. Blend so that it becomes / ml (both units are purprogarin units).
以下、実施例により本発明を詳述するが、先ず、用いた
試験法およびペルオキシダーゼの種類は次のとおりであ
る。Hereinafter, the present invention will be described in detail with reference to Examples. First, the test methods and types of peroxidases used are as follows.
I)過酸化水素濃度の測定 被験体溶液を酸素測定反応槽〔Type BOM−11,(株)石
川製作所,東京〕に入れ、外気と遮断した後、攪拌しな
がらカタラーゼ(牛肝臓製,Pharmacia P−L Biochemica
ls Inc.)1,500単位/10μlを添加し、過酸化水素の分
解により発生する酸素量を溶存酸素電極〔Type DG−5,
(株)石川製作所〕によつて測定した。過酸化水素濃度
は発生した溶存酸素濃度から算出した。I) Measurement of hydrogen peroxide concentration The test solution was placed in an oxygen measurement reaction tank [Type BOM-11, Ishikawa Seisakusho Co., Ltd., Tokyo], and after being shielded from the outside air, catalase (manufactured by beef liver, Pharmacia P -L Biochemica
ls Inc.) 1,500 units / 10 μl was added, and the amount of oxygen generated by the decomposition of hydrogen peroxide was measured by the dissolved oxygen electrode [Type DG-5,
Ishikawa Seisakusho Co., Ltd.]. The hydrogen peroxide concentration was calculated from the generated dissolved oxygen concentration.
II)突然変異原性試験 突然変異原性はサルモネラ変異原性試験(Salmonella m
utagenicity test)(Ames,B.N.et al.,Mutation Res.,
Vol.31,347−364,1975)と、ジフテリア毒素耐性を指標
としたチヤイニーズハムスター肺線維芽細胞(CHL細
胞)(Nakasato,F.,Mutation Res.,Vol.141,109−112,1
984)を用いて行なつた。II) Mutagenicity test Mutagenicity is the Salmonella mutagenicity test (Salmonella m
utagenicity test) (Ames, BNet al., Mutation Res.,
Vol.31,347-364,1975) and Chinese hamster lung fibroblasts (CHL cells) using diphtheria toxin resistance as an index (Nakasato, F., Mutation Res., Vol.141,109-112,1).
984).
(1)サルモネラ変異原性試験 プレインキュベーション法(Sugimura,T.およびM.Naga
o,:F.J.de SerresおよびA.Hollaender(共編),Chemica
l Mutagens,Principles and Methods for Their detect
ion,Vol.6,Plenum,ニユーヨーク,pp41−66,1980)によ
る。使用菌株はサルモネラ・テイフイムリウム(Salmon
ella typhimuritum)TA100株(以下、“S.TA100株”と
略す)を用いた。(1) Salmonella mutagenicity test Preincubation method (Sugimura, T. and M. Naga
o,: FJ de Serres and A. Hollaender (co-edited), Chemica
l Mutagens, Principles and Methods for Their detect
ion, Vol.6, Plenum, New York, pp41-66, 1980). The strain used is Salmonella teifimulium ( Salmon
ella typhimuritum ) TA100 strain (hereinafter abbreviated as “S.TA100 strain”) was used.
(i)試料の調製 イ)コーヒー:インスタントコーヒー(粉末)は蒸留水
に溶かす。レギュラーコーヒーの場合、焙煎コーヒー豆
をその20g当り250mlの熱蒸留水で抽出し、抽出液をコー
ヒーフイルターペーパー(カリタ製No.12)で過す
る。液を凍結乾燥し、乾重量を測定後蒸留水に溶か
す。(I) Preparation of sample i) Coffee: Instant coffee (powder) is dissolved in distilled water. In the case of regular coffee, roasted coffee beans are extracted with 250 ml of hot distilled water per 20 g of the coffee, and the extract is passed through coffee filter paper (Carita No. 12). The solution is freeze-dried, the dry weight is measured, and then the solution is dissolved in distilled water.
ロ)クリーム:インスタント粉末クリームの場合は蒸留
水に所定濃度になるように溶かす。ペルオキシダーゼを
クリームに配合する場合はラクトースを賦形剤として所
定量を噴霧造粒法により配合した。液状クリーミングの
場合は、ペルオキシダーゼを所定量だけ添加し、溶解さ
せた。B) Cream: In the case of instant powder cream, dissolve in distilled water to a prescribed concentration. When peroxidase was added to the cream, a predetermined amount was added using lactose as an excipient by a spray granulation method. In the case of liquid creaming, a predetermined amount of peroxidase was added and dissolved.
ハ)紅茶:市販の紅茶2.5gを200mlの沸騰した蒸留水で
抽出し、抽出後に葉を除去し、抽出液を減圧下40℃でエ
バポレータにより乾燥させ、残渣をジメチルスルフオキ
サイド(DMSO)に溶解する。C) Black tea: 2.5 g of commercially available black tea is extracted with 200 ml of boiling distilled water, the leaves are removed after extraction, the extract is dried under reduced pressure at 40 ° C with an evaporator, and the residue is converted to dimethylsulfoxide (DMSO). Dissolve.
(ii)突然変異原性の測定 上記イ)〜ハ)により得られた各試料を単独、あるいは
混合〔イ)とロ)、ロ)とハ)〕後いずれも100μlと
し、これに、500μlの100mMリン酸ナトリウム緩衝液
(pH7.4)と100μlのS.TA100株培養液を加えたものを
加える。この混合液を37℃で20分間振とう後、溶解した
2mlの軟寒天に混ぜ、0.1%グルコース寒天プレートに拡
げる。なお、前記軟寒天には菌をプレート上で数回分裂
させるのに必要な0.1μmole/2ml軟寒天/プレートのL
−ヒスチジンを加えておく。37℃で48時間静置後、プレ
ート上のコロニー数を復帰突然変異株として数える。(Ii) Measurement of mutagenicity Each of the samples obtained by the above a) to c) was used alone, or after mixing [a] and b), b) and c)], 100 μl was added to each, and 500 μl of this was added. Add 100 mM sodium phosphate buffer (pH 7.4) and 100 μl of S.TA100 strain culture solution. This mixture was shaken at 37 ° C for 20 minutes and then dissolved
Mix in 2 ml of soft agar and spread on a 0.1% glucose agar plate. For the soft agar, 0.1 μmole / 2 ml soft agar / plate L necessary for dividing the bacteria several times on the plate was used.
-Add histidine. After standing at 37 ° C for 48 hours, count the number of colonies on the plate as revertant strains.
(2)ジフテリア毒素抵抗性細胞出現を指標とする突然
変異試験 Nakayasuらの方法により試験した〔Nakayasu,M.et al.,
Carcinogenesis,Vol.3,917−922,1982;坂本及び寺田、
トキシコロジーフオーラム,Vol.8(2),101−104,198
5〕。(2) Mutation test using the appearance of diphtheria toxin-resistant cells as an index Tested by the method of Nakayasu et al. [Nakayasu, M. et al.,
Carcinogenesis, Vol.3,917-922,1982; Sakamoto and Terada,
Toxicology Forum, Vol.8 (2), 101-104, 198
Five〕.
突然変異原性試験開始の48時間前にCHL細胞を0.25%ト
リプシンを用いてフラスコより遊離させ、1×105個の
細胞を5.5cm2のチューブ(A/C,Nunc社)に移す。48 hours before the start of the mutagenicity test, CHL cells are released from the flask using 0.25% trypsin, and 1 × 10 5 cells are transferred to a 5.5 cm 2 tube (A / C, Nunc).
被験体をCHL細胞と3時間37℃で培養した後、培養液を
除き、トリプシン処理で細胞を遊離し細胞を10%胎児牛
血清を含むVAMEM〔ビタミン類、アミノ酸類を加えたMEM
培地(Eagle′s minimum essential medium)〕で3回
洗う。細胞毒性の測定には、被験体と培養したCHL細胞
および被験体を含まない培養液で培養したCHL細胞を60m
mのシヤーレに200〜400個まき、7〜8日間培養する。
細胞をメタノールで固定し、ギムザ染色をする。細胞数
50個以上のコロニーをコロニーとして数える。細胞毒性
は細胞生存率として表わすが、生存率は、被験体処理細
胞のコロニー形成率の、未処理細胞のコロニー形成率に
対する比率であらわす。After culturing the subject with CHL cells at 37 ° C for 3 hours, the culture solution was removed, and the cells were released by trypsin treatment and the cells were VAMEM containing 10% fetal bovine serum [MEM containing vitamins and amino acids.
Wash 3 times with medium (Eagle's minimum essential medium)]. For measurement of cytotoxicity, CHL cells cultured with a subject and CHL cells cultured in a culture medium containing no subject were treated with 60 m
Sprinkle 200 to 400 seeds on a m-chalet and incubate for 7 to 8 days.
The cells are fixed with methanol and stained with Giemsa. Number of cells
Count more than 50 colonies as colonies. Cytotoxicity is expressed as cell viability, which is the ratio of the colony formation rate of subject-treated cells to the colony formation rate of untreated cells.
突然変異率を測定するためには、細胞を被験体と培養し
た後、1×105〜3×105個の細胞を25cm2のフラスコに
移し、10mlの10%胎児牛血清を含む培養液で7〜8日間
(発現期間に相当する)培養する。この間1回、細胞を
トリプシンではがし、他のフラスコに播きなおし、細胞
を常に増殖期の状態に保つておく。発現期間の後、2.5
×105個の細胞を90mmのシヤーレに移し、10mlの10%胎
児牛血清を含むVAMEMを加える。3〜4時間後、ジフテ
リア毒素を0.1Lf/mlの濃度で加える。同時に発現期間
後、200〜400個の細胞を60mmのシヤーレに移し、5mlの1
0%胎児牛血清を含むVAMEMで7〜8日間培養し、コロニ
ー形成率を測定する。突然変異率はジフテリア毒素存在
下に形成したコロニー数を毒素の存在しない状態におけ
るコロニー数で割り、2.5×105生存細胞あたりの突然変
異率としてあらわす。To measure the mutation rate, after culturing the cells with the subject, transfer 1 × 10 5 to 3 × 10 5 cells to a 25 cm 2 flask and add 10 ml of 10% fetal bovine serum to the culture medium. Culture for 7 to 8 days (corresponding to the expression period). During this time, the cells are once stripped with trypsin and reseeded in another flask to keep the cells in the growth phase at all times. After the onset period, 2.5
× 10 5 cells are transferred to a 90 mm dish and 10 ml of VAMEM containing 10% fetal bovine serum is added. After 3-4 hours, diphtheria toxin is added at a concentration of 0.1 Lf / ml. Simultaneously after the expression period, transfer 200-400 cells to a 60 mm dish and add 5 ml of 1
The cells are cultured in VAMEM containing 0% fetal bovine serum for 7 to 8 days, and the colony formation rate is measured. The mutation rate is expressed as the mutation rate per 2.5 × 10 5 viable cells by dividing the number of colonies formed in the presence of diphtheria toxin by the number of colonies in the absence of toxin.
この系における変異原性の強さはサルモネラ菌に対する
変異原性の強さより、その被験体の発癌性の強さとより
よい相関関係がある。The mutagenic potency in this system correlates better with the carcinogenic potency of the subject than the mutagenic potency against Salmonella.
(3)ヒト小腸細胞に対する細胞毒性試験 ヒト小腸上皮細胞(Intestine407)を、6穴シヤーレ
(底面積9.6cm2×6)に9.2×103細胞/2mlずつ播き、10
%胎児牛血清を含むMEM培地(Eagle′s minimal essent
ial medium)中で3日間CO2ガス培養器により培養す
る。3日後、MEMを取り除き、被験体をMEM又はPBSにて
溶解し、2mlずつシヤーレに加え3時間CO2ガス培養器中
に放置後、被験体を含むMEM又はPBSを除去する。更にME
Mを交換し、3日間培養する。培養後、細胞をPBSで洗浄
し、メタノール固定後ギムザ染色を行なう。細胞毒性
(細胞障害度)は5段階評価する。(3) Cytotoxicity test against human small intestinal cells Human small intestinal epithelial cells (Intestine 407) were seeded on a 6-well dish (bottom area 9.6 cm 2 × 6) by 9.2 × 10 3 cells / 2 ml each, and 10
MEM medium containing% fetal bovine serum (Eagle's minimal essent
Incubate for 3 days in a CO 2 gas incubator. After 3 days, the MEM is removed, the subject is dissolved in MEM or PBS, 2 ml each is added to the dish, and left in a CO 2 gas incubator for 3 hours, and then the MEM or PBS containing the subject is removed. Further ME
Replace M and incubate for 3 days. After culturing, the cells are washed with PBS, fixed with methanol and stained with Giemsa. Cytotoxicity (degree of cytotoxicity) is evaluated in 5 levels.
III)ペルオキシダーゼ 下記のペルオキシダーゼについて試験した。III) Peroxidase The following peroxidases were tested.
(1)ペルオキシダーゼ〔西洋ワサビ由来;120単位※/m
g:東洋紡績(株)、大阪〕 (2)ペルオキシダーゼ〔西洋ワサビ由来;180単位※/m
g:天野製薬(株)、名古屋〕 ※いずれも、プルプロガリン単位 実施例 (1)ペルオキシダーゼ配合のクリームのコーヒー、紅
茶中の過酸化水素分解効果 前記II)(i)イ)およびハ)の方法で調製したレギユ
ラーコーヒー及び紅茶中に20分間に発生する過酸化水素
に対し、ペルオキシダーゼ配合のクリーム(西洋ワサビ
由来、6プルプロガリン単位/g粉末クリーム)をコーヒ
ーもしくは紅茶各150ml当り3g添加すると瞬時にこれを
分解した(第4図)。クリームの添加量はレギュラーコ
ーヒー、紅茶とも1ml当たり20mgであつた。(1) Peroxidase [derived from horseradish; 120 units * / m
g: Toyobo Co., Ltd., Osaka) (2) Peroxidase [derived from horseradish; 180 units * / m
g: Amano Pharmaceutical Co., Ltd., Nagoya] * All are purpurogallin units Example (1) Hydrogen peroxide decomposition effect in coffee and tea containing cream containing peroxidase II) (i) b) and c) To the hydrogen peroxide generated in the prepared regular coffee and tea for 20 minutes, peroxidase blended cream (from horseradish, 6 purpurogallin unit / g powder cream) was added instantly when 3g of coffee or tea of 150ml was added. Was disassembled (Fig. 4). The amount of cream added was 20 mg per ml for both regular coffee and black tea.
(2)過酸化水素の分解と突然変異原性の不活性化蒸留
水にインスタントコーヒーを溶かして10分経過後、ペル
オキシダーゼ(西洋ワサビ製、10単位/mlコーヒー)を
添加し過酸化水素を分解した。このとき、S.TA100に対
する突然変異原性も不活性化した(第5図)。第5図に
よれば、コーヒーの突然変異原性は、コーヒー中に発生
する過酸化水素量と密な相関関係をもつが、ペルオキシ
ダーゼは過酸化水素と変異原性を極めて有効に消失させ
ることが認められる。また、ペルオキシダーゼを限外ロ
過により取り除くと、両者とも再び元のレベルまで戻る
ことから、本酵素の作用は可逆的であることもわかつ
た。但しペルオキシダーゼで長時間(少くとも1時間)
処理するか、ペルオキシダーゼの基質となる電子受容体
を添加し、コーヒー中の電子供与体を完全に反応消費す
れば、コーヒー中の過酸化水素に由来する変異原は不可
逆的で消失する。(2) Decomposition of hydrogen peroxide and mutagenic inactivation Dissolve instant coffee in distilled water, and after 10 minutes, add peroxidase (horseradish, 10 units / ml coffee) to decompose hydrogen peroxide. did. At this time, the mutagenicity against S.TA100 was also inactivated (Fig. 5). According to FIG. 5, the mutagenicity of coffee has a close correlation with the amount of hydrogen peroxide generated in coffee, but peroxidase can extinguish hydrogen peroxide and mutagenicity extremely effectively. Is recognized. Moreover, it was also found that the action of this enzyme is reversible, because both of them return to their original levels when the peroxidase is removed by ultrafiltration. However, with peroxidase for a long time (at least 1 hour)
Upon treatment or addition of an electron acceptor serving as a substrate for peroxidase to completely react and consume the electron donor in coffee, the mutagen derived from hydrogen peroxide in coffee disappears irreversibly.
第6図AおよびBは、コーヒーの変異原性をペルオキシ
ダーゼ(POD)の長時間処理によつて不可逆的に不活性
化する方法について、データとして示すものである。PO
Dを配合しないときのコーヒーのS.テイフイムリウムTA1
00株に対する変異原性を100%とすると、POD(0.125〜
1.25単位/mlコーヒー溶液)を配合し、かつ長時間反応
させたときほど変異原性は不可逆的に消失し、例えばPO
D(前記濃度)を2時間37℃で振とうしながら反応させ
ると変異原性の約90%は不可逆的に失活する。FIGS. 6A and 6B show as data the method of irreversibly inactivating the mutagenicity of coffee by long-term treatment with peroxidase (POD). PO
Coffee S. Tefimurium TA1 without D
If the mutagenicity for strain 00 is 100%, POD (0.125 ~
1.25 units / ml coffee solution) and the longer the reaction time, the more mutagenicity is irreversibly lost.
About 90% of the mutagenicity is irreversibly inactivated by reacting D (the above concentration) for 2 hours with shaking at 37 ° C.
一方、上記の結果は、CHL細胞においても確められた。
すなわち、インスタントコーヒーのCHL細胞に対する突
然変異原性はペルオキシダーゼ配合クリームの添加(5
単位/mlコーヒー)により著しく低減した。(第7
図)。ペルオキシダーゼの効果は、哺乳動物を対象とし
ても確認された。On the other hand, the above results were also confirmed in CHL cells.
That is, the mutagenicity of instant coffee against CHL cells was determined by adding the cream containing peroxidase (5
(Unit / ml coffee) significantly reduced. (7th
Figure). The effect of peroxidase was also confirmed in mammals.
(3)ペルオキシダーゼ配合クリームによるコーヒー及
び紅茶の細胞毒性の軽減。(3) Reduction of cytotoxicity of coffee and black tea with cream containing peroxidase.
市販のクリーム(クリーミングパウダー)にペルオキシ
ダーゼ〔東洋紡績(株)製〕を噴霧造粒して配合クリー
ムを製造した。本クリームをPBS(リン酸生理食塩水)
に0.015単位分/ml添加したところ、インスタントコーヒ
ー及び紅茶のヒト小腸上皮細胞に対する細胞毒性を著し
く軽減した(第8図,第9図)。ペルオキシダーゼを配
合しないクリームでは何ら効果は認められなかつた(第
8図,第9図)。クリームとしては、他に市販のクリー
ミングパウダー3種、液状クリーム2種について、コー
ヒーや紅茶に添加しその効果を検討したが、クリーム無
添加コーヒーと同一結果を示し、細胞毒性に関し効果は
認められなかった。A commercially available cream (creaming powder) was spray-granulated with peroxidase (manufactured by Toyobo Co., Ltd.) to produce a compounding cream. This cream is PBS (phosphate saline)
The addition of 0.015 units / ml of citrate significantly reduced the cytotoxicity of instant coffee and tea on human small intestinal epithelial cells (Figs. 8 and 9). No effect was observed with the cream containing no peroxidase (Figs. 8 and 9). As for cream, other 3 kinds of commercially available creaming powder and 2 kinds of liquid cream were added to coffee or black tea and the effect was examined, but the same result as coffee without cream was shown, and no effect was observed on cytotoxicity. It was
(4)ペルオキシダーゼ配合クリームの耐熱性。(4) Heat resistance of cream containing peroxidase.
本クリームの耐熱性について検討した。前述した効果を
示すのに充分な酵素活性は、10分間の煮沸で失なわれた
が、コーヒー、紅茶の通常の飲用形態を想定した条件、
すなわち、80℃、10分間処理では、1gあたり6単位の酵
素を含むクリームは、過酸化水素の分解、細胞毒性、突
然変異原性の著しい低下作用を発揮した。酵素量を10倍
に増やせば、90℃で5分間処理しても充分な酵素活性を
残し、飲用時に沸騰水がコツプ内でさめるわずかの時間
(通常1〜2分程度)を見込めば充分に実用性がある。
また、クリームの変質劣化、溶解性や凝固性の悪化等品
質の低下は、ペルオキシダーゼを配合したことにより生
じなかつた。同時に、本クリームのコーヒー、紅茶の嗜
好性に及ぼす影響については、ペルオキシダーゼを配合
したことにより、味、香りは損なわれておらず、この点
についても実用上問題はなかつた。The heat resistance of this cream was examined. Enzyme activity sufficient to show the above-mentioned effect was lost by boiling for 10 minutes, but the conditions assuming normal drinking forms of coffee and tea,
That is, when treated at 80 ° C. for 10 minutes, the cream containing 6 units of enzyme per gram exhibited remarkable effects of decomposing hydrogen peroxide, cytotoxicity and mutagenicity. If the amount of enzyme is increased 10 times, sufficient enzyme activity will remain even if treated at 90 ° C for 5 minutes, and it will be sufficient if the boiling water is allowed to cool for a short time (usually about 1 to 2 minutes). There is practicality.
In addition, deterioration of the cream such as deterioration and deterioration of solubility and coagulation did not occur due to the addition of peroxidase. At the same time, regarding the effect of this cream on the palatability of coffee and tea, the addition of peroxidase did not impair the taste and aroma, and there was no practical problem in this regard.
調製例(ペルオキシダーゼ配合クリーム) 合成クリーム製造の常法に準じて、合成クリーム1g当り
6単位のペルオキシダーゼを含むクリームを製造した。
すなわち、米糠油、硬化ヤシ油からなる原料油脂に、
水、コーンシロツプ、大豆蛋白、乳酸ステロールナトリ
ウム、ポリソルベート、二リン酸ナトリウム、二リン酸
カリウム、ピロリン酸およびペルオキシダーゼを配合
し、ホイツプを行なつた。ついで65℃にて、均質化し、
バツチ式殺菌を80℃10分間行ない、その後急速冷却し、
5℃にて10時間エージングし、ペルオキシダーゼ配合ク
リームを得た。ペルオキシダーゼは乳化剤としても作用
し、乳化を安定させた。Preparation Example (Cream containing Peroxidase) A cream containing 6 units of peroxidase per 1 g of the synthetic cream was produced according to a conventional method for producing a synthetic cream.
That is, in the raw material oil and fat consisting of rice bran oil and hardened coconut oil
Water, corn syrup, soy protein, sodium sterol lactate, polysorbate, sodium diphosphate, potassium diphosphate, pyrophosphate and peroxidase were mixed and whipped. Then homogenize at 65 ° C,
Perform batch sterilization at 80 ° C for 10 minutes, then cool rapidly,
Aging was performed at 5 ° C. for 10 hours to obtain a peroxidase-containing cream. Peroxidase also acted as an emulsifier and stabilized the emulsification.
第1図はコーヒー溶液からの過酸化水素発生を示すグラ
フであり、 第2図は市販クリームがコーヒーの突然変異原性を不活
性化しないことを示すグラフであり、 第3図は市販クリームがコーヒーのヒト小腸細胞に対す
る細胞毒性を不活性化しないことを示すグラフであり、 第4図はペルオキシダーゼ配合クリームのコーヒー、紅
茶中の過酸化水素分解効果を示すグラフであり、 第5図は、コーヒー中に発生した過酸化水素量と突然変
異原性との関係を、ペルオキシダーゼによるこれらの不
活性化により調べた結果を示すグラフであり、 第6図Aはコーヒーの変異原性の不可逆的な不活性化の
検討方法を示す工程図であり、 第6図Bはコーヒーの変異原性の不可逆的な不活性化を
示すグラフであり、 第7図はペルオキシダーゼ配合クリームによるインスタ
ントコーヒーの突然変異原性の不活性化を示すグラフで
あり、 第8図はペルオキシダーゼ配合クリームによるコーヒー
の細胞毒性の軽減を示すグラフであり、 第9図はペルオキシダーゼ配合クリームによる紅茶の細
胞毒性の軽減を示すグラフである。FIG. 1 is a graph showing hydrogen peroxide generation from a coffee solution, FIG. 2 is a graph showing that commercial cream does not inactivate the mutagenicity of coffee, and FIG. 3 is a graph showing that commercial cream does not. Fig. 4 is a graph showing that coffee does not inactivate the cytotoxicity to human small intestinal cells, Fig. 4 is a graph showing the hydrogen peroxide decomposing effect of peroxidase-containing cream in coffee and tea, and Fig. 5 is coffee. FIG. 6A is a graph showing the results of investigating the relationship between the amount of hydrogen peroxide generated in cells and mutagenicity by inactivating these with peroxidase. FIG. FIG. 6 is a process chart showing a method for examining activation, FIG. 6B is a graph showing irreversible inactivation of coffee mutagenicity, and FIG. 7 is a peroxidase-containing cream. Fig. 8 is a graph showing inactivation of mutagenicity of instant coffee by Fig. 8, Fig. 8 is a graph showing reduction of coffee cytotoxicity by cream containing peroxidase, and Fig. 9 is cytotoxicity of black tea by cream containing peroxidase. It is a graph which shows reduction of.
Claims (1)
する飲料用クリーム。1. A beverage cream comprising a peroxidase.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13541786A JPH0789863B2 (en) | 1986-06-11 | 1986-06-11 | Cream for beverages containing peroxidase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13541786A JPH0789863B2 (en) | 1986-06-11 | 1986-06-11 | Cream for beverages containing peroxidase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62294032A JPS62294032A (en) | 1987-12-21 |
| JPH0789863B2 true JPH0789863B2 (en) | 1995-10-04 |
Family
ID=15151245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13541786A Expired - Lifetime JPH0789863B2 (en) | 1986-06-11 | 1986-06-11 | Cream for beverages containing peroxidase |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0789863B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011116052A3 (en) * | 2010-03-18 | 2011-12-22 | Land O'lakes Purina Feed Llc | Enhanced lactoperoxidase system for treatment of milk products |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009011271A1 (en) * | 2007-07-13 | 2009-01-22 | Ogawa & Co., Ltd. | Degradation inhibitor for flavor or aroma |
-
1986
- 1986-06-11 JP JP13541786A patent/JPH0789863B2/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011116052A3 (en) * | 2010-03-18 | 2011-12-22 | Land O'lakes Purina Feed Llc | Enhanced lactoperoxidase system for treatment of milk products |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62294032A (en) | 1987-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ayub et al. | Development of an instant-mix probiotic beverage based on fermented quinoa with reduced phytate content | |
| Zainoldin et al. | The effect of Hylocereus polyrhizus and Hylocereus undatus on physicochemical, proteolysis, and antioxidant activity in yogurt | |
| Sanchez | Philippine fermented foods: principles and technology | |
| Karaçalı et al. | Aromatic and functional aspects of kefir produced using soya milk and Bifidobacterium species | |
| EP2540307B1 (en) | Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage | |
| Frias et al. | Natural fermentation of lentils. Influence of time, flour concentration, and temperature on the kinetics of monosaccharides, disaccharide, and α-galactosides | |
| Chawafambira et al. | Effect of Lacticaseibacillus rhamnosus yoba fermentation on physicochemical properties, amino acids, and antioxidant activity of cowpea‐peanut milk | |
| RS50695B (en) | FERMENTED PROTEIN PRODUCT | |
| KR102148099B1 (en) | Enzyme food composite manufacture method using Isolated Soy Protein and brown rice | |
| JP4119656B2 (en) | Antioxidant | |
| KR102015783B1 (en) | Black ginseng fermented jelly and its manufacturing method | |
| KR20190001795A (en) | Enzyme food composite manufacture method using Isolated Soy Protein and brown rice | |
| Ishiwu et al. | Effect of period of fermentation on nutrients of Castor oil seed (Ricinus communis) | |
| KR101507704B1 (en) | Composition for detoxification or relieving hangover comprising fermented natural plant as effective component | |
| Bintari et al. | Development and properties of tegurt, a yogurt-like tempe product | |
| JPH0789863B2 (en) | Cream for beverages containing peroxidase | |
| KR102586000B1 (en) | Lactobacillus fermentum HDB1098 that selectively degrades acetaldehyde and composition for removing hangover containing the same as an active ingredient | |
| CN115428908B (en) | A kind of preparation method of Bacillus cereus-assisted fermentation sausage | |
| RU2503242C2 (en) | Fermented soya bean milk and method for improvement of organoleptic properties of fermented soya bean milk | |
| Daysita et al. | Characterization and shelf life of synbiotic drink powder from porang (Amorphophallus muelleri) | |
| JP3238554B2 (en) | Production method of coffee beverage containing dairy ingredients | |
| Oyarekua | Biochemical and microbiological changes during the production of fermented pigeon pea (Cajanus cajan) flour | |
| CA3140926A1 (en) | Methods of processing a fava bean composition | |
| Yusuf | Quality and storage stability of yoghurt produced from pigeon pea milk supplemented with Propionibacterium freudenreichii | |
| Cadena et al. | Microbiological and physicochemical characterization of a traditionally fermented corn product:" Champús" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |